The ability of IMCβγ or IMC30-40 − IMC15-25 to differentiate patients with SCA3 or SCA6 from neurotypical subjects or the other SCA subtype was assessed using ROC analysis (Fig. 3). This evidence concerns the gene CACNA1A and autosomal dominant cerebellar ataxia.